5-Fluoronorepinefrin
| |
| Nazivi | |
|---|---|
| Preferisani IUPAC naziv
5-(2-amino-1-hidroksietil)-3-fluorobenzen-1,2-diol | |
| Drugi nazivi
Benzeneetanamin, 3-fluoro-beta,4,5-trihidroksi-
CHEMBL129190 Benzeneetanamin, 3-fluoro-.beta.,4,5-trihidroksi- CMXBGHSRBYAOPP-UHFFFAOYSA-N BDBM50042998 5-(2-Amino-1-hidroksietil)-3-fluoro-1,2-benzendiol 5-(2-Amino-1-hidroksi-etil)-3-fluoro-benzen-1,2-diol 5-FNE | |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C8H10FNO3 | |
| Molarna masa | 187,17 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
5-Fluoronorepinefrin je agonist beta adrenergičkog receptora.[3]
Reference[уреди | уреди извор]
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ G T Chen; M King; F Gusovsky; C R Creveling; J W Daly; B H Chen; J Y Nie; K L Kirk (1993). „Syntheses of 2,5- and 2,6-difluoronorepinephrine, 2,5-difluoroepinephrine, and 2,6-difluorophenylephrine: effect of disubstitution with fluorine on adrenergic activity”. J Med Chem. стр. 3947—55. doi:10.1021/jm00076a024.